Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effect of Cardiac Rehabilitation on Outcomes in Patients with ST-Elevation Myocardial Infarction.

Lee HY, Hong SJ, Jung IH, Kim GS, Byun YS, Kim BO.

Yonsei Med J. 2019 Jun;60(6):535-541. doi: 10.3349/ymj.2019.60.6.535.

2.

Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF.

Coron Artery Dis. 2008 Jun;19(4):271-7. doi: 10.1097/MCA.0b013e3282f487e0.

PMID:
18480672
3.
4.

Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.

Zhang Q, Shen J, Zhang RY, Qiu JP, Lu JD, Zhang Y, Chen YH, Zhang JF, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF.

Chin Med J (Engl). 2007 Nov 5;120(21):1862-7.

PMID:
18067756
5.

One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.

Liu HW, Han YL, Jin QM, Wang XZ, Ma YY, Wang G, Wang B, Xu K, Li Y, Chen SL.

Chin Med J (Engl). 2018 Jun 20;131(12):1412-1419. doi: 10.4103/0366-6999.233948.

6.
7.

Impact of Postprocedural TIMI Flow on Long-Term Clinical Outcomes in Patients with Acute Myocardial Infarction.

Kim DW, Her SH, Park MW, Cho JS, Kim TS, Kang H, Sim DS, Hong YJ, Kim JH, Ahn Y, Chang K, Chung WS, Seung KB, Jeong MH, Rho TH.

Int Heart J. 2017 Oct 21;58(5):674-685. doi: 10.1536/ihj.16-448. Epub 2017 Sep 30.

8.

Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial).

Di Lorenzo E, Sauro R, Capasso M, Lanni F, Lanzillo T, Carbone G, Manganelli F, Palmieri V, Serino V, Pagliuca MR, Rosato G, Suryapranata H, De Luca G.

Int J Cardiol. 2016 Jan 1;202:177-82. doi: 10.1016/j.ijcard.2015.08.123. Epub 2015 Aug 16.

PMID:
26397405
9.

Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents in ST elevation myocardial infarction: findings from the Guthrie Health Off-label Stent (GHOST) Registry.

Sattur S, Orshaw P, Boura J, Harjai KJ.

J Interv Cardiol. 2012 Apr;25(2):118-25. doi: 10.1111/j.1540-8183.2011.00703.x. Epub 2012 Feb 10.

PMID:
22324820
10.
11.

Long-term outcomes of intravascular ultrasound-guided implantation of bare metal stents versus drug-eluting stents in primary percutaneous coronary intervention.

Cho YK, Hur SH, Park NH, Choi SW, Sohn JH, Cho HO, Park HS, Yoon HJ, Kim H, Nam CW, Kim YN, Kim KB.

Korean J Intern Med. 2014 Jan;29(1):66-75. doi: 10.3904/kjim.2014.29.1.66. Epub 2014 Jan 2.

12.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).

Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.

JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129. Epub 2013 May 15.

13.

Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Celık T, Balta S, Demır M, Yıldırım AO, Kaya MG, Ozturk C, Demırkol S, Unlu M, Kılıc S, Aydın İ, Iyısoy A.

Cardiol J. 2016;23(1):84-92. doi: 10.5603/CJ.a2015.0070. Epub 2015 Oct 27.

14.

Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis.

Jo HS, Park JS, Sohn JW, Yoon JC, Sohn CW, Lee SH, Hong GR, Shin DG, Kim YJ, Jeong MH, Chae SC, Hur SH, Hong TJ, Seong IW, Chae JK, Rhew JY, Chae IH, Cho MC, Bae JH, Rha SW, Kim CJ, Choi DH, Jang YS, Yoon JH, Chung WS, Seung KB, Park SJ.

Korean Circ J. 2011 Dec;41(12):718-25. doi: 10.4070/kcj.2011.41.12.718. Epub 2011 Dec 31.

15.

Complete Versus Culprit-Only Revascularization for ST-Segment Elevation Myocardial Infarction and Multivessel Disease in the 2nd Generation Drug-Eluting Stent Era: Data from the INTERSTELLAR Registry.

Kwon SW, Park SD, Moon J, Oh PC, Jang HJ, Park HW, Kim TH, Lee K, Suh J, Kang W.

Korean Circ J. 2018 Nov;48(11):989-999. doi: 10.4070/kcj.2017.0387.

16.

Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.

Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, Browne K, Iwaoka R, Azrin M, Stapleton D, Setum C, Popma J; AIMI Investigators.

J Am Coll Cardiol. 2006 Jul 18;48(2):244-52. Epub 2006 Jun 23.

17.

Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.

Topuz M, Oz F, Akkus O, Sen O, Topuz AN, Bulut A, Ozbicer S, Okar S, Koc M, Gur M.

Perfusion. 2017 Apr;32(3):206-213. doi: 10.1177/0267659116676335. Epub 2016 Oct 22.

PMID:
27770057
19.

Clinical outcomes of complete revascularization using either angiography-guided or fractional flow reserve-guided drug-eluting stent implantation in non-culprit vessels in ST elevation myocardial infarction patients: insights from a study based on a systematic review and meta-analysis.

Hideo-Kajita A, Garcia-Garcia HM, Kuku KO, Beyene SS, Azizi V, Meirovich YF, Melaku GD, Dheendsa A, Brathwaite EJ, Desale S, Soud M, Dan K, Ozaki Y, Waksman R, Lipinski M.

Int J Cardiovasc Imaging. 2018 Sep;34(9):1349-1364. doi: 10.1007/s10554-018-1362-9. Epub 2018 May 19.

PMID:
29779179
20.

Safety and effectiveness of the Genous™ endothelial progenitor cell-capture stent in the first year following ST-elevation acute myocardial infarction: A single center experience and review of the literature.

Pereira-da-Silva T, Bernardes L, Cacela D, Fiarresga A, Sousa L, Patrício L, Ferreira RC.

Cardiovasc Revasc Med. 2013 Nov-Dec;14(6):338-42. doi: 10.1016/j.carrev.2013.09.004. Epub 2013 Nov 9.

PMID:
24216000

Supplemental Content

Support Center